Viela Bio, Inc. (VIE) relating to its proposed acquisition by Horion Therapeutics plc. Under the terms of the tender offer, VIE shareholders are expected to receive $53.00 per share they own.
Viela Bio, Inc. (VIE) relating to its proposed acquisition by Horion Therapeutics plc. Under the terms of the tender offer, VIE shareholders are expected to receive $53.00 per share they own.